206 related articles for article (PubMed ID: 4139980)
21. [Epstein-Barr virus antibody pattern in lymphoproliferative disorders in children and young adults].
Nordan U; Vansover A; Gottlieb-Stematzky T
Harefuah; 1973 Nov; 85(9):395-7. PubMed ID: 4359830
[No Abstract] [Full Text] [Related]
22. [Present status of infectious mononucleosis and Epstein Barr virus].
Ducroix JP; Smail A; Vovan AT; Devauchelle B; Baillet J
LARC Med; 1984 Mar; 4(3):161-3. PubMed ID: 6325836
[No Abstract] [Full Text] [Related]
23. [Infectious mononucleosis. Determination of immunofluorescent antibodies against the Epstein-Barr virus and complement-fixation antibodies against the cytomegalovirus].
Lasovská J; Kouba K; Sobĕslavský O; Seeman J; Moravcová E; Kucharská Z; Vojtĕchovský K
Cas Lek Cesk; 1973 Jan; 112(2):38-42. PubMed ID: 4345614
[No Abstract] [Full Text] [Related]
24. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact.
Gray J; Wreghitt TG; Pavel P; Smyth RL; Parameshwar J; Stewart S; Cary N; Large S; Wallwork J
J Heart Lung Transplant; 1995; 14(4):640-6. PubMed ID: 7578169
[TBL] [Abstract][Full Text] [Related]
25. [Antibody formation against specific Epstein-Barr virus antigens in infectious mononucleosis with tonsillectomy in the acute phase of the disease].
Sauerbrei A; Sprössig M; Wutzler P; Färber I; Schweizer H; Swoboda R; Wilke J
Laryngol Rhinol Otol (Stuttg); 1983 Apr; 62(4):170-4. PubMed ID: 6191167
[TBL] [Abstract][Full Text] [Related]
26. Serological follow-up of children with infectious mononucleosis caused by Epstein-Barr virus.
Timár L; Koller M; Budai J
Acta Paediatr Acad Sci Hung; 1981; 22(3):243-9. PubMed ID: 6272540
[TBL] [Abstract][Full Text] [Related]
27. [Serum antibodies against Epstein-Barr virus in infectious mononucleosis].
Gsell HO; Löffler H; Müller B
Schweiz Med Wochenschr; 1970 Mar; 100(11):495-500. PubMed ID: 4334794
[No Abstract] [Full Text] [Related]
28. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
[TBL] [Abstract][Full Text] [Related]
29. [Antibodies against the Epstein-Barr virus, capsid antigen in children with malignant neoplasms (author's transl)].
Lubec G; Krepler P
Padiatr Padol; 1976; 11(1):88-93. PubMed ID: 175342
[TBL] [Abstract][Full Text] [Related]
30. Discordance of Epstein-Barr Virus (EBV) specific humoral and cellular immunity in patients with malignant lymphomas: elevated antibody titres and lowered in vitro lymphocyte reactivity.
Ten Napel CH; The TH; Van Egten-Bijker J; de Gast GC; Halie MR; Langenhuysen MM
Clin Exp Immunol; 1978 Dec; 34(3):338-46. PubMed ID: 217561
[TBL] [Abstract][Full Text] [Related]
31. [Antibodies against the Epstein-Barr Virus nuclear-antigen in children with malignant disease (author's transl)].
Lubec G; Jürgenssen O
Osterr Z Onkol; 1976; 3(4):96-9. PubMed ID: 189271
[TBL] [Abstract][Full Text] [Related]
32. Antibody patterns in different human sera against intracellular and membrane-antigen complexes associated with Epstein-Barr virus.
Svedmyr A; Demissie A; Klein G; Clifford P
J Natl Cancer Inst; 1970 Mar; 44(3):595-610. PubMed ID: 11515428
[No Abstract] [Full Text] [Related]
33. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
[TBL] [Abstract][Full Text] [Related]
34. Antibody to Epstein-Barr virus in man in Australia and New Guinea.
Pope JH; Walters MK; Scott W; Gunz FW
Int J Cancer; 1973 Nov; 12(3):689-98. PubMed ID: 4364798
[No Abstract] [Full Text] [Related]
35. Infectious mononucleosis and Epstein-Barr virus in Japan. I. Clinical and serological aspects.
Takiuchi Y; Tatsumi E; Shirakawa S; Uchino H
Nihon Ketsueki Gakkai Zasshi; 1980 Aug; 43(4):700-10. PubMed ID: 6261511
[No Abstract] [Full Text] [Related]
36. Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis.
Miller G; Niederman JC; Andrews LL
N Engl J Med; 1973 Feb; 288(5):229-32. PubMed ID: 4345064
[No Abstract] [Full Text] [Related]
37. Production of migration inhibitory factor (MIF) by human leukocytes following exposure to Epstein-Barr virus.
Wilson GL; Young BG
Cell Immunol; 1978 Jun; 38(1):147-56. PubMed ID: 208782
[No Abstract] [Full Text] [Related]
38. Specific neutralizing antibodies in Epstein-Barr virus associated diseases.
Rocchi G; Hewetson J; Henle W
Int J Cancer; 1973 May; 11(3):637-47. PubMed ID: 4364719
[No Abstract] [Full Text] [Related]
39. Radioiodine-labeled antibody test for the detection of membrane antigens associated with Epstein-Barr virus.
Hewetson JF; Gothoskar B; Klein G
J Natl Cancer Inst; 1972 Jan; 48(1):87-94. PubMed ID: 4347031
[No Abstract] [Full Text] [Related]
40. Phenotype and frequency of Epstein-Barr virus-infected cells in pretreatment blood samples from patients with Hodgkin lymphoma.
Khan G; Lake A; Shield L; Freeland J; Andrew L; Alexander FE; Jackson R; Taylor PR; McCruden EA; Jarrett RF
Br J Haematol; 2005 May; 129(4):511-9. PubMed ID: 15877733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
